World J Mens Health.  2017 Aug;35(2):107-114. 10.5534/wjmh.2017.35.2.107.

Erectile Dysfunction in Men with and without Lower Urinary Tract Symptoms in Nigeria

• Adegun PT
• Areo PO
• Solomon A
• Dada SA
• Adebayo PB

• KMID: 2388446
• DOI: http://doi.org/10.5534/wjmh.2017.35.2.107

Abstract

PURPOSE
Much attention has been focused in recent decades on the effects of erectile dysfunction (ED) secondary to lower urinary tract symptoms (LUTS), potentially underestimating its effects in men without LUTS. This study aimed to compare the prevalence and predictors of ED in men with and without LUTS.
MATERIALS AND METHODS
The International Index of Erectile Function questionnaire was administered to 303 patients between January 2014 and June 2016. Within this sample, 147 patients with LUTS (cases) were compared to 156 men without LUTS who were matched for age, level of education, and occupation (controls).
RESULTS
The mean age was 66.03±9.64 years and 65.78±8.61 years for the cases and controls, respectively. The prevalence of ED was 64.6% and 73.7% (odds ratio [OR], 1.54; 95% confidence interval [CI], 0.94∼2.51) in the case cohort and controls, respectively (p=0.086). There was no difference in the prevalence of impaired erectile function (p=0.067), impaired orgasmic function (p=0.108), impaired sexual desire (p=0.291), impaired intercourse satisfaction (p=0.869), or impaired overall satisfaction (p=0.191). Multivariate logistic regression analysis showed that being currently employed was a significant predictor of ED both in men with LUTS (OR, 8.08; 95% CI, 1.51∼9.27; p=0.004) and in men without LUTS (OR, 7.00; 95% CI, 1.49∼14.51; p=0.008). Being married only predicted for impaired EF in men without LUTS (OR, 6.34; 95% CI, 1.40∼15.20; p<0.05).
CONCLUSIONS
ED was not found to be more prevalent in men with LUTS. Being employed was a predictor of ED in both groups of men, while being married was also a predictor of ED in men without LUTS.

Keyword

Epidemiology; Erectile dysfunction; Lower urinary tract symptoms; Nigeria; Prevalence

MeSH Terms

Cohort Studies
Education
Epidemiology
Erectile Dysfunction*
Humans
Logistic Models
Lower Urinary Tract Symptoms*
Male
Nigeria*
Occupations
Orgasm
Prevalence

Reference

1. Shaeer KZ, Osegbe DN, Siddiqui SH, Razzaque A, Glasser DB, Jaguste V. Prevalence of erectile dysfunction and its correlates among men attending primary care clinics in three countries: Pakistan, Egypt, and Nigeria. Int J Impot Res. 2003; 15(Suppl 1):S8–S14. PMID: 12825103.

2. Eardley I. The incidence, prevalence, and natural history of erectile dysfunction. Sex Med Rev. 2013; 1:3–16. PMID: 27784558.

3. Idung AU, Abasiubong F, Ukott IA, Udoh SB, Unadike BC. Prevalence and risk factors of erectile dysfunction in Niger delta region, Nigeria. Afr Health Sci. 2012; 12:160–165. PMID: 23056022.

4. Altin M, Hughes RD, Williams R. Neutrophil adherence during hemoperfusion in fulminant hepatic failure. Int J Artif Organs. 1982; 5:315–317. PMID: 7174138.

5. Garko SB, Ogunsina MO, Danbauchi SS. Sexual dysfunction in hypertensive patients: implications for therapy. Ann Afr Med. 2005; 4:46–51.

6. Oyekanmi AK, Adelufosi AO, Abayomi O, Adebowale TO. Demographic and clinical correlates of sexual dysfunction among Nigerian male outpatients on conventional antipsychotic medications. BMC Res Notes. 2012; 5:267. PMID: 22676295.

7. Hackett GI, Milledge D. A 12-month follow up of 260 patients taking sildenafil. NHS clinical experience. In : Fourth Congress of the European Society for Sexual and Impotence Research (ESSIR); 2001 Sep 30∼Oct 3; Rome, Italy. poster 171.

8. Piores OM, Jimeno CA, Acampado LT. Erectile dysfunction among diabetes men at UP-PGH outpatient department: prevalence and risk factors. Phil J Internal Medicine. 2004; 42:197–202.

9. Oladiji F, Kayode OO, Parakoyi DB. Influence of sociodemographic characteristics on prevalence of erectile dysfunction in Nigeria. Int J Impot Res. 2013; 25:18–23. PMID: 22895099.

10. Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int J Impot Res. 2000; 12:305–311. PMID: 11416833.

11. Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol. 2003; 44:637–649. PMID: 14644114.

12. Shabsigh R, Anastasiadis AG. Erectile dysfunction. Annu Rev Med. 2003; 54:153–168. PMID: 12525671.

13. Montorsi F, Briganti A, Salonia A, Rigatti P, Burnett AL. Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy. Eur Urol. 2004; 45:123–133. PMID: 14733995.

14. Finger WW, Lund M, Slagle MA. Medications that may contribute to sexual disorders. A guide to assessment and treatment in family practice. J Fam Pract. 1997; 44:33–43. PMID: 9010369.

15. Braun MH, Sommer F, Haupt G, Mathers MJ, Reifenrath B, Engelmann UH. Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical “Aging Male” symptoms? Results of the “Cologne Male Survey”. Eur Urol. 2003; 44:588–594. PMID: 14572759.

16. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997; 49:822–830. PMID: 9187685.

17. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994; 151:54–61. PMID: 8254833.

18. Olarinoye JK, Kuranga SA, Katibi IA, Adediran OS, Jimoh AA, Sanya EO. Prevalence and determinants of erectile dysfunction among people with type 2 diabetes in Ilorin, Nigeria. Niger Postgrad Med J. 2006; 13:291–296. PMID: 17203117.

19. Olugbenga-Bello AI, Adeoye OA, Adeomi AA, Olajide AO. Prevalence of erectile dysfunction (ED) and its risk factors among adult men in a Nigerian community. Niger Postgrad Med J. 2013; 20:130–135. PMID: 23959355.

20. Ariba AJ, Oladopo OT, Iyaniwura CA, Dada OA. Management of erectile dysfunction: perceptions and practices of Nigerian primary care clinicians. SA Fam Pract. 2007; 49:16–29.

21. Shelbaia A, Elsaied WM, Elghamrawy H, Abdullah A, Salaheldin M. Effect of selective alpha-blocker tamsulosin on erectile function in patients with lower urinary tract symptoms due to benign prostatic hyperplasia. Urology. 2013; 82:130–135. PMID: 23711438.

22. Yong DJ, Lee KC, Cho IR. The effect of lower urinary tract symptoms on erectile function and the frequency of sexual intercourse. Korean J Urol. 2007; 48:458–462.

23. Lee JH. Associations between premature ejaculation, lower urinary tract symptoms, and erectile dysfunction in middle-aged Korean policemen. J Sex Med. 2014; 11:1512–1518. PMID: 24528521.

24. Gray P, Campbell B. Erectile dysfunction and its correlates among the Ariaal of northern Kenya. Int J Impot Res. 2005; 17:445–449. PMID: 16015378.

25. Malavaud B, Mouzin M, Tricoire JL, Gamé X, Rischmann P, Sarramon JP, et al. Evaluation of male sexual function after pelvic trauma by the International Index of Erectile Function. Urology. 2000; 55:842–846. PMID: 10840088.

26. Gacci M, Eardley I, Giuliano F, Hatzichristou D, Kaplan SA, Maggi M, et al. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol. 2011; 60:809–825. PMID: 21726934.